FDA Approves First Treatment for Hutchinson-Gilford Progeria Syndrome and Certain Progoid Laminopathies
[ad_1] For immediate release: November 20, 2020 Today, the United States Food and Drug Administration approved Zokinvy (lonafarnib) capsules to reduce the risk of death from Hutchinson-Gilford progeria syndrome and for the treatment of certain treatment-deficient progeroid laminopathies in patients aged one year and over. Zokinvy is not approved for use in patients with other … Read more